Celyad Oncology

CYAD

CYAD Celyad Oncology NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    CYAD Chart
    See on advanced chart >

    About

    Founded in 2007, Celyad Oncology SA is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and...
    • Highlight
      A biotechnology company focused on chimeric antigen receptor T cell therapies for cancer
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/19/2015
    • Established Date
      Invalid Date
    • Full-time Employees
      28
    • Address
      Axis Business Park Rue Edouard Belin 2 BE-1435 Mont-Saint-Guibert, Brabant wallon Belgium
    • Tel
      32-10-394100
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      American Depositary Receipt (Common Stock)
    cache time: 2024-04-23 23:44:55